The Novo Nordisk drug was compared to Trulicity in its SUSTAIN 7 trial ... Once approved, this oral version could open up a much bigger diabetes market, as the need to inject GLP-1 drugs still ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

Diabetes medications like Ozempic and Trulicity are typically covered, while weight loss drugs like Wegovy and Saxenda face limited coverage unless specific health criteria are met. Ren-Fielding ...

“Stelara, an auto-immune biologic, has become a key earner for Johnson & Johnson, and the diabetes drug Trulicity is expected to enjoy strong sales momentum over the forecast period 2018-2025." ...

Co.’s Trulicity. The researchers didn’t compare the Novo drugs with Lilly’s newer diabetes shot, Mounjaro. With assistance from Madison Muller.

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Thousands of Americans are diagnosed with Type 1 diabetes every year, according to the American Diabetes Association. But a new medication now available worldwide has the potential to drive that ...

Semaglutide, the same compound that’s in Ozempic, is part of a class of medications known as glucagon-like peptide 1 (GLP-1) ...

Metformin, a chemical relative of that compound, has been a top type 2 diabetes treatment in the United States since it was approved in 1994. It’s cheap—less than a dollar per dose—and readily ...